Ibrutinib, Venetoclax Plus CD20 Monoclonal Ab Provides Very High MRD Negativity in Previously Untreated MCL Patients, Initial Results of OASIS II, a Randomized Phase 2 Trial - Le Gouill, Steven; de Wilde, Virginie; Eyre, Toby A.; Callanan, Mary B.; Damaj, Gandhi; Claudel, Alexis; Chauchet, Adrien; Houot, Roch; Le Calloch, Ronan; Cacheux, Victoria; André, Marc; Morschhauser, Franck; et al. (Blood, 2024)
Keywords: Cancer; Life Sciences